Israel Health Ministry study finds COVID shots unrelated to cardiac events by studying only vaccinated

A new study from Israel’s Health Ministry has reportedly found that the COVID-19 vaccines are unrelated to cardiac events and strokes. Kann News, which described the study as “very large”, said the ministry looked at vaccinated people who suffered cardiac events or strokes within one month of the injections, and vaccinated people who suffered cardiac events or strokes over a month after the shots. The study found no difference between the two groups. 

The study did not include unvaccinated people.

Frontline News was unable to obtain a copy of the study despite requests to Kann News and the Health Ministry. The ministry responded that if we want access to the study we must file a Freedom of Information request, which would likely take several months. 

We also asked the Health Ministry for its comment on a peer-reviewed study from the Massachusetts Institute of Technology (MIT) last year which found that a recent 25% increase in cardiac events in young men is directly correlated to the COVID-19 vaccines. 

The MIT researchers studied emergency calls in Israel, one of the most highly vaccinated countries in the world, over a two-and-a-half-year period spanning 2019–2021. Specifically, they looked at emergency calls reporting either cardiac arrests (CA) or acute coronary syndrome (ACS) in the 16-39 age group. 

The study also aimed to determine if the uptick in cardiovascular events was associated with COVID-19 or the COVID-19 vaccine. The findings showed that for the period January–May 2021 there was a 25% increase in emergency cardiovascular events compared with the same period in 2019 and 2020, and entirely associated with the COVID-19 shot.  

“Using Negative Binomial regression models, the weekly emergency call counts were significantly associated with the rates of 1st and 2nd vaccine doses administered to this age group but were not with COVID-19 infection rates,” says the MIT study.  

The authors then question the safety of the vaccine saying the study “underscores the need for the thorough investigation of the apparent association between COVID-19 vaccine administration and adverse cardiovascular outcomes among young adults.” 

Regarding strokes, Kann News said they are clearly a result of COVID itself. 

“I can tell you that the virus itself, COVID itself — when one gets sick with COVID — there are studies around the world which show that it increases the danger of strokes, because it is known that the COVID virus causes blood clots,” said Kann News’ Ketty Dor. 

However, a study published in the Vaccines journal last year sounded the alarm over blood clots caused by the mRNA COVID-19 vaccine.  

The study conducted a retrospective analysis of data harvested from VigiBase, the World Health Organization’s (WHO) drug safety database. It found that of 1,154,023 adverse events reported for the mRNA-based COVID-19 vaccines, 756 (0.07%) were for cerebral venous thrombosis (CVT), a blood clot that forms in the brain and is accompanied by headaches, stroke-related symptoms, and seizures.  

“Our study demonstrated a potential safety signal for occurrence of CVT for COVID-19 mRNA vaccination,” the study concluded. “It is necessary to be aware of the risk of CVT occurrence, even after COVID-19 mRNA vaccination.”  

Oddly, Pfizer came up with an even larger percentage figure in 2021 but reached a different conclusion.  

In its Cumulative Analysis of Post-Authorization Adverse Events Reports, Pfizer analyzes 42,086 adverse events from the COVID vaccine up to February 28, 2021. Of those events, Pfizer reports 300 cases of cerebrovascular venous and sinus thrombosis (CVST), which is 0.71% of the total number of cases.  

Of the 300 CVST cases, Pfizer's report records 61 fatalities, 61 resolved/resolving, 10 resolved with sequelae — where the illness leaves behind a lasting condition, 85 unresolved and 83 unknown.  

But Pfizer’s verdict was the opposite of the study’s authors.  

“Conclusion: This cumulative case review does not raise new safety issues. Surveillance will continue.”